Option 1 uses the
following equations::
Cockcroft and Gault equation
utilizing the ibw (Ideal body weight) to calculate an estimated creatinine clearance.
Cockcroft and Gault equation:
CrCl = [(140 - age) x IBW] / (Scr x 72)
(x 0.85 for females)
Note: if the ABW (actual body weight) is less than the IBW use
the actual body weight for calculating the CRCL. If the patient is
>65yo and creatinine<1.0, use 1 to calculate the creatinine
clearance.
(Note: Some clinician's feel that rounding the serum
creatinine to 1.0 in the elderly will result in underestimation of
clearance. Recommendation: Follow your local protocol.
Estimate Ideal body weight in (kg)
Males: IBW = 50 kg + 2.3 kg for each inch over 5 feet.
Females: IBW = 45.5 kg + 2.3 kg for each inch over 5 feet.
Option
2 (equations):
Cockcroft and Gault equation
utilizing the adjusted body weight to calculate an estimated creatinine clearance.
CrCl = [(140 - age) x AjBW]
---------------------------------
(Scr x 72)
Note: (Multiply result by 0.85 for
females)
AjBW = adjusted body weight:
AjBW = IBW + 0.3( ABW - IBW)
Estimated IBW:
Males: IBW = 50 kg + 2.3 kg for each inch over 5 feet.
Females: IBW = 45.5 kg + 2.3 kg for each inch over 5 feet.
Key points:
Note that the adjusted body weight equation uses 0.3 as a correction
factor compared to the aminoglycoside's adjusted body weight equation which
uses 0.4
Also, the adjusted body weight is not calculated unless the actual body
weight is 25% greater than the ideal body weight. In all other cases,
the ideal body weight is used.
Some studies have shown that utilizing
the adjusted body weight improves accuracy compared to other commonly
used equations in estimating the creatinine clearance in the elderly population.
Option 3 (equation):
Simplified 4-variable MDRD study formula11
GFR = 186.3 x (SCR)-1.154
x (age in years)-0.203 x 1.212 (if patient
is black) x 0.742 (if female)
Key point:
Early statistical analysis shows very
promising results. This may be especially true in chronic kidney disease.
4) Dettli LC. Drug dosage in patients with
renal disease. Clin Pharmacol Ther 1974;16:274-80.
5) Drusano LG, Munice HL, Hoopes JM et al.
Commonly used methods of estimating creatinine clearance are inadequate
for elderly debilitated nursing home patients. J Am Geriatrics Soc
1998;36:437-41.
6) Hailemeskel B, Namanny M, Kurz A.
Estimating aminoglycoside dosage requirements in patients with low serum
creatinine concentrations. Am J Health-Syst Pharm 1997;54:986-7.
7) Jelliffe RW. Estimation of creatinine
clearance when urine cannot be collected. Lancet 1971;1:975-6.
8) Levey AS, Greene T, Kusek JW, et al. A
simplified equation to predict glomerular filtration rate from serum
creatinine (Abstr) J Am Soc Nephrol 2000;(11):155A
9) Levey AS, Greene T, Schluchter MD, et
al. Glomerular filtration rate measurements in clinical trials.
Modification of Diet in Renal Disease Study Group and the Diabetes
Control and Complications Trial Research Group. J Am Soc Nephrol
1993;4(5):1159-71
10) Levey AS. Assessing the effectiveness
of therapy to prevent the progression of renal disease. Am J Kidney Dis
1993;22(1):207-14
11) Levey AS, Bosch JP, Lewis JB, et al. A
more accurate method to estimate glomerular filtration rate from serum
creatinine: a new prediction equation. Modification of Diet in Renal
Disease Study Group. Ann Intern Med 1999;130(6):461-70
12) Rhodes RS, Sims PJ, Culbertson VL et
al. Accuracy of creatinine clearance estimates in geriatric males with
elevated serum creatinine clearance. J Geriatric Drug Ther 1991;5:31-45.
13) Smythe M, Hoffman J, Kizy K et al.
Estimating creatinine clearance in elderly patients with low serum
creatinine concentrations. Am J Hosp Pharm 1994;51:189-204.
Disclaimer
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgement. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
CAREFULLY
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read
the disclaimer